company background image
SIPC

Sabaa International Company for Pharmaceutical and Chemical IndustryCASE:SIPC Stock Report

Market Cap

ج.م270.5m

7D

-0.04%

1Y

41.4%

Updated

21 Oct, 2021

Data

Company Financials
SIPC fundamental analysis
Snowflake Score
Valuation0/6
Future Growth0/6
Past Performance2/6
Financial Health5/6
Dividends0/6

SIPC Overview

Sabaa International Company for Pharmaceutical and Chemical Industry, a research based pharmaceutical company, provides generic medicines in Egypt.

Price History & Performance

Summary of all time highs, changes and price drops for Sabaa International Company for Pharmaceutical and Chemical Industry
Historical stock prices
Current Share Priceج.م5.41
52 Week Highج.م3.58
52 Week Lowج.م7.57
Beta0.65
1 Month Change-0.037%
3 Month Change-11.29%
1 Year Change41.37%
3 Year Change134.98%
5 Year Change192.83%
Change since IPO28.85%

Recent News & Updates

Shareholder Returns

SIPCEG PharmaceuticalsEG Market
7D-0.04%-2.6%-0.8%
1Y41.4%0.1%11.1%

Return vs Industry: SIPC exceeded the EG Pharmaceuticals industry which returned -0.9% over the past year.

Return vs Market: SIPC exceeded the EG Market which returned 9.2% over the past year.

Price Volatility

Is SIPC's price volatile compared to industry and market?
SIPC volatility
SIPC Beta0.65
Industry Beta0.85
Market Beta1

Stable Share Price: SIPC is less volatile than 75% of EG stocks over the past 3 months, typically moving +/- 2% a week.

Volatility Over Time: SIPC's weekly volatility (2%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
n/a165Sahal Morsi Al-Damrawihttps://www.sabaapharmagroup.com

Sabaa International Company for Pharmaceutical and Chemical Industry, a research based pharmaceutical company, provides generic medicines in Egypt. It offers drugs in the areas of anti-bacterial, anti-depressant, anti-eplieptic, anti-fungal, anti-hyperlipidemic, anti-hypertension, anti-platelet, anti-pspriasis, anti-viral, cardiovascular, cosmeceutical, diabetology, musculoskeletal, and renal. The company is based in Cairo, Egypt.

Sabaa International Company for Pharmaceutical and Chemical Industry Fundamentals Summary

How do Sabaa International Company for Pharmaceutical and Chemical Industry's earnings and revenue compare to its market cap?
SIPC fundamental statistics
Market Capج.م270.50m
Earnings (TTM)ج.م13.46m
Revenue (TTM)ج.م70.16m

20.1x

P/E Ratio

3.9x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report
SIPC income statement (TTM)
Revenueج.م70.16m
Cost of Revenueج.م28.61m
Gross Profitج.م41.54m
Expensesج.م28.08m
Earningsج.م13.46m

Last Reported Earnings

Sep 30, 2020

Next Earnings Date

n/a

Earnings per share (EPS)0.27
Gross Margin59.21%
Net Profit Margin19.19%
Debt/Equity Ratio18.2%

How did SIPC perform over the long term?

See historical performance and comparison

Valuation

Is Sabaa International Company for Pharmaceutical and Chemical Industry undervalued compared to its fair value and its price relative to the market?

20.09x

Price to Earnings (PE) ratio


Share Price vs. Fair Value

Below Fair Value: Insufficient data to calculate SIPC's fair value to establish if it is undervalued.

Significantly Below Fair Value: Insufficient data to calculate SIPC's fair value to establish if it is undervalued.


Price To Earnings Ratio

PE vs Industry: SIPC is poor value based on its PE Ratio (20.1x) compared to the EG Pharmaceuticals industry average (5.9x).

PE vs Market: SIPC is poor value based on its PE Ratio (20.1x) compared to the EG market (11.6x).


Price to Earnings Growth Ratio

PEG Ratio: Insufficient data to calculate SIPC's PEG Ratio to determine if it is good value.


Price to Book Ratio

PB vs Industry: SIPC is overvalued based on its PB Ratio (2.7x) compared to the EG Pharmaceuticals industry average (1.4x).


Future Growth

How is Sabaa International Company for Pharmaceutical and Chemical Industry forecast to perform in the next 1 to 3 years based on estimates from 0 analysts?

14.3%

Forecasted Pharmaceuticals & Biotech industry annual growth in earnings


In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as Sabaa International Company for Pharmaceutical and Chemical Industry has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.

This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.


Past Performance

How has Sabaa International Company for Pharmaceutical and Chemical Industry performed over the past 5 years?

688.8%

Last years earnings growth


Earnings and Revenue History

Quality Earnings: SIPC has a high level of non-cash earnings.

Growing Profit Margin: SIPC's current net profit margins (19.2%) are higher than last year (3%).


Past Earnings Growth Analysis

Earnings Trend: Insufficient data to determine if SIPC's year-on-year earnings growth rate was positive over the past 5 years.

Accelerating Growth: Insufficient data to compare SIPC's past year earnings growth to its 5-year average.

Earnings vs Industry: SIPC earnings growth over the past year (688.8%) exceeded the Pharmaceuticals industry 10%.


Return on Equity

High ROE: SIPC's Return on Equity (13.2%) is considered low.


Financial Health

How is Sabaa International Company for Pharmaceutical and Chemical Industry's financial position?


Financial Position Analysis

Short Term Liabilities: SIPC's short term assets (EGP70.8M) exceed its short term liabilities (EGP16.5M).

Long Term Liabilities: SIPC's short term assets (EGP70.8M) exceed its long term liabilities (EGP12.8M).


Debt to Equity History and Analysis

Debt Level: SIPC's debt to equity ratio (18.2%) is considered satisfactory.

Reducing Debt: SIPC's debt to equity ratio has increased from 10.2% to 18.2% over the past 5 years.

Debt Coverage: SIPC's debt is well covered by operating cash flow (75.2%).

Interest Coverage: SIPC's interest payments on its debt are well covered by EBIT (24.8x coverage).


Balance Sheet


Dividend

What is Sabaa International Company for Pharmaceutical and Chemical Industry current dividend yield, its reliability and sustainability?


Dividend Yield vs Market

Notable Dividend: Unable to evaluate SIPC's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.

High Dividend: Unable to evaluate SIPC's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.


Stability and Growth of Payments

Stable Dividend: Insufficient data to determine if SIPC's dividends per share have been stable in the past.

Growing Dividend: Insufficient data to determine if SIPC's dividend payments have been increasing.


Current Payout to Shareholders

Dividend Coverage: SIPC is not paying a notable dividend for the EG market.


Future Payout to Shareholders

Future Dividend Coverage: No need to calculate the sustainability of SIPC's dividend in 3 years as they are not forecast to pay a notable one for the EG market.


Next Steps

Management

How experienced are the management team and are they aligned to shareholders interests?


CEO

Sahal Morsi Al-Damrawi

no data

Tenure

Mr. Sahal Morsi Mohamad Al-Damrawi serves as Managing Director and Director at Sabaa International Company for Pharmaceutical and Chemical Industry and served as its Vice Chairman of the Board of Directors...


Ownership

Who are the major shareholders and have insiders been buying or selling?


Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.


Ownership Breakdown

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.


Top Shareholders

Company Information

Sabaa International Company for Pharmaceutical and Chemical Industry's employee growth, exchange listings and data sources


Key Information

  • Name: Sabaa International Company for Pharmaceutical and Chemical Industry
  • Ticker: SIPC
  • Exchange: CASE
  • Founded: NaN
  • Industry: Pharmaceuticals
  • Sector: Pharmaceuticals & Biotech
  • Market Cap: ج.م270.500m
  • Shares outstanding: 50.00m
  • Website: https://www.sabaapharmagroup.com

Number of Employees


Location

  • Sabaa International Company for Pharmaceutical and Chemical Industry
  • 6, Ahmed Shaker St.
  • Villa Al Madaen
  • Cairo
  • Egypt

Listings


Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2021/10/21 14:32
End of Day Share Price2021/10/20 00:00
Earnings2020/09/30
Annual Earnings2019/12/31


Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.